Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN113563235B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113563235B reveals a greener synthesis route for MMP inhibitor intermediates, replacing toxic reagents with mild oxidative chlorination for cost reduction.